Kanser Sonrası Nüksler ve Diğer Birincil Kanserler İçin Yaşam Yönetimi
Özet
Kanser tedavisi sonrası süreçte hastaların onkoloji ve birinci basamak sağlık hizmetlerini koordineli şekilde alamamaları, nüks sürveyansı ve yeni birincil kanserlerin takibinde kritik eksiklikler doğurmaktadır. Erken tanı ve gelişen tedaviler sayesinde hayatta kalan hasta sayısı hızla artmakta, bu nüfusun büyük kısmını 60 yaş üzeri bireyler oluşturmaktadır. Küratif tedavi sonrasında dahi tüm hastalar bölgesel nüks veya metastatik hastalık riskiyle karşı karşıyadır ancak izlem protokollerinin yetersiz kaldığı gözlenmektedir. Ayrıca, kemoterapi ve radyoterapinin kümülatif dozlarına, genetik faktörlere veya yaşam tarzına bağlı olarak ikinci bir birincil kanser gelişme riski de oldukça yüksektir. Tedavilerin geç etkileri arasında kardiyotoksisite, pulmoner fibrozis, infertilite ve nörolojik bozukluklar gibi ciddi fiziksel ve psikososyal sorunlar yer almaktadır. Bu süreçte birinci basamak hekimlerinin eğitimi ile onkoloji ekipleri arasındaki koordinasyon, hastaların yaşam kalitesini artırmak ve mortaliteyi azaltmak adına hayati önem taşır. Diyet, fiziksel aktivite, sigara ve alkolü bırakma gibi önleyici bakımların yanı sıra diyabet ve kardiyovasküler komorbiditelerin yönetimi de tüm nedenlere bağlı ölüm riskini azaltmaktadır.
In the post-cancer treatment period, the lack of coordinated oncology and primary care services causes critical deficiencies in recurrence surveillance and the follow-up of subsequent primary cancers. Thanks to early diagnosis and advanced treatments, the number of survivors is rapidly increasing, with the majority of this population consisting of individuals over the age of 60. Even after curative treatment, all patients face the risk of regional recurrence or metastatic disease, yet follow-up protocols remain inadequate. Furthermore, the risk of developing a second primary cancer is substantially high due to cumulative doses of chemotherapy and radiotherapy, genetic factors, or lifestyle choices. Late effects of treatments include severe physical and psychosocial issues such as cardiotoxicity, pulmonary fibrosis, infertility, and neurological disorders. In this process, the training of primary care physicians and coordination with oncology teams are vital to improve patients' quality of life and reduce mortality. Preventive care, including diet, physical activity, and smoking and alcohol cessation, alongside the management of comorbidities like diabetes and cardiovascular diseases, reduces the risk of all-cause mortality.
Referanslar
Elston Lafata J, Simpkins J, Schultz L, et al. Routine surveillance care after cancer treatment with curative intent. Med Care 2005; 43:592.
Salloum RG, Hornbrook MC, Fishman PA, et al. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer 2012; 118:5644.
Keating NL, Landrum MB, Guadagnoli E, et al. Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol 2007; 25:1074.
Cooper GS, Kou TD, Reynolds HL Jr. Receipt of guideline-recommended follow-up in older colorectal cancer survivors : a population-based analysis. Cancer 2008; 113:2029.
Snyder CF, Earle CC, Herbert RJ, et al. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol 2008; 26:1073.
Snyder CF, Earle CC, Herbert RJ, et al. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med 2008; 23:254.
Snyder CF, Frick KD, Kantsiper ME, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol 2009; 27:1054.
Snyder CF, Frick KD, Peairs KS, et al. Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med 2009; 24:469.
Snyder CF, Frick KD, Herbert RJ, et al. Preventive care in prostate cancer patients: following diagnosis and for five-year survivors. J Cancer Surviv 2011; 5:283.
Keating NL, Landrum MB, Guadagnoli E, et al. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol 2006; 24:85.
Nekhlyudov L, Mollica MA, Jacobsen PB, et al. Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and Policy. J Natl Cancer Inst 2019; 111:1120.
American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2019-2021. American Cancer Society, Atlanta, 2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2019-2021.pdf (Accessed on January 20, 2020).
Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019; 69:363.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022; 72:7.
American Cancer Society. Cancer Treatment & Survivorship Facts & Figures, 2016-2017. American Cancer Society; Atlanta, GA 2016.
Hewitt M, Greenfield S, Stovall E, et al. From cancer patient to cancer survivor: Lost in transition. National Academies Press, Washington DC, 2006. https://canceradvocacy.org/wp-content/uploads/2013/01/From-Cancer-Patient-to-Cancer-Survivor-Lost-in-Transition-Summary-.pdf (Accessed on June 02, 2021).
Doubeni CA, Field TS, Ulcickas Yood M, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer 2006; 106:2482.
Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R. Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract 2010; 6:174.
Potosky AL, Han PK, Rowland J, et al. Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med 2011; 26:1403.
Kok JL, Teepen JC, van der Pal HJ, et al. Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer. JAMA Oncol 2019; 5:671.
Sung H, Hyun N, Leach CR, et al. Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States. JAMA 2020; 324:2521.
Ng AK, Bernardo MP, Weller E, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002; 20:2101.
Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003; 21:3431.
Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer 2008; 123:2390.
Chao C, Bhatia S, Xu L, et al. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer. JAMA Netw Open 2019; 2:e195536.
Turcotte LM, Liu Q, Yasui Y, et al. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort. J Clin Oncol 2019; 37:3310.
Veiga LH, Curtis RE, Morton LM, et al. Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study. JAMA Pediatr 2019; 173:1171.
Wood ME, Vogel V, Ng A, et al. Second malignant neoplasms: assessment and strategies for risk reduction. J Clin Oncol 2012; 30:3734.
Wang Z, Wilson CL, Easton J, et al. Genetic Risk for Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer. J Clin Oncol 2018; 36:2078.
AlDubayan SH, Conway JR, Camp SY, et al. Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma. JAMA 2020; 324:1957.
Ganz PA, Casillas JN. Incorporating the Risk for Subsequent Primary Cancers Into the Care of Adult Cancer Survivors: Moving Beyond 5-Year Survival. JAMA 2020; 324:2493.
Cullinan N, Schiller I, Di Giuseppe G, et al. Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors. J Clin Oncol 2021; 39:3207.
Bright CJ, Reulen RC, Winter DL, et al. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study. Lancet Oncol 2019; 20:531.
Travis LB, Bhatia S, Allan JM, et al. Second primary cancers. In: DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 9th ed, DePinho RA, Lawrence TS, Rosenberg SA, Weinberg RA (Eds), Lippincott Williams & Wilkins, Philadelphia 2011. p.2393.
Henderson TO, Moskowitz CS, Chou JF, et al. Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 2016; 34:910.
Moskowitz CS, Chou JF, Neglia JP, et al. Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 2019; 37:2120.
Bowers DC, Nathan PC, Constine L, et al. Subsequent neoplasms of the CNS among survivors of childhood cancer: A systematic review. Lancet Oncol 2013; 14:e321.
Schneider AB, Shore-Freedman E, Ryo UY, et al. Radiation-induced tumors of the head and neck following childhood irradiation. Prospective studies. Medicine (Baltimore) 1985; 64:1.
Haddy N, El-Fayech C, Guibout C, et al. Thyroid adenomas after solid cancer in childhood. Int J Radiat Oncol Biol Phys 2012; 84:e209.
Teepen JC, Kok JL, van Leeuwen FE, et al. Colorectal Adenomas and Cancers After Childhood Cancer Treatment: A DCOG-LATER Record Linkage Study. J Natl Cancer Inst 2018; 110:758.
Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57:75.
Children's Oncology Group: Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers http://www.survivorshipguidelines.org/ (Accessed on June 02, 2021).
Yeh JM, Lowry KP, Schechter CB, et al. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study. Ann Intern Med 2020; 173:331.
Moskowitz CS, Ronckers CM, Chou JF, et al. Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER Cohorts. J Clin Oncol 2021; 39:3012.
Yan AP, Chen Y, Henderson TO, et al. Adherence to Surveillance for Second Malignant Neoplasms and Cardiac Dysfunction in Childhood Cancer Survivors: A Childhood Cancer Survivor Study. J Clin Oncol 2020; 38:1711.
Oeffinger KC, Ford JS, Moskowitz CS, et al. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 2009; 301:404.
Bowers DC, Verbruggen LC, Kremer LCM, et al. Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 2021; 22:e196.
American Cancer Society. Cancer Treatment and Survivorship Facts & Figures 2012-2013. American Cancer Society; Atlanta, GA 2012.
Armstrong GT, Chen Y, Yasui Y, et al. Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. N Engl J Med 2016; 374:833.
Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers. Version 4.0, Children's Oncology Group; Arcadia, CA 2008.
Bhatia S. Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors. Cancer Epidemiol Biomarkers Prev 2011; 20:2048.
Yahalom J, Portlock CS. Toxicity. In: DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 9th ed, DePinho RA, Lawrence TS, Rosenberg SA, Weinberg RA (Eds), Lippincott Williams & Wilkins, Philadelphia 2011. p.2360.
Norian JM, Feinberg EC, DeCherney AH, Armstrong AY. Gonadal dysfunction. In: De Vita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 9th ed, DePinho RA, Lawrence TS, Rosenberg SA, Weinberg RA (Eds), Lippincott Williams & Wilkins, Philadelphia 2011. p.2372.
Stubblefield MD. Rehabilitation of the cancer patient. In: DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 9th ed, DePinho RA, Lawrence TS, Rosenberg SA, Weinberg RA (Eds), Lippincott Williams & Wilkins, Philadelphia 2011. p.2503.
Ruddy KJ, Partridge AH. Fertility (male and female) and menopause. J Clin Oncol 2012; 30:3705.
Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol 2012; 30:3687.
Lenihan DJ, Cardinale DM. Late cardiac effects of cancer treatment. J Clin Oncol 2012; 30:3657.
Bhakta N, Liu Q, Ness KK, et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet 2017; 390:2569.
Marcucci G, Beltrami G, Tamburini A, et al. Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors. Ann Oncol 2019; 30:908.
Clemens E, van den Heuvel-Eibrink MM, Mulder RL, et al. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Lancet Oncol 2019; 20:e29.
Weil BR, Madenci AL, Liu Q, et al. Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 2018; 36:1571.
Armenian SH, Xu L, Ky B, et al. Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. J Clin Oncol 2016; 34:1122.
Mulrooney DA, Armstrong GT, Huang S, et al. Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study. Ann Intern Med 2016; 164:93.
Ganz PA. Survivorship: adult cancer survivors. Prim Care 2009; 36:721.
Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995; 273:1450.
Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119:1977.
Sutradhar R, Lokku A, Barbera L. Cancer survivorship and opioid prescribing rates: A population-based matched cohort study among individuals with and without a history of cancer. Cancer 2017; 123:4286.
Vitzthum LK, Riviere P, Sheridan P, et al. Predicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors. J Natl Cancer Inst 2020; 112:720.
Barbera L, Sutradhar R, Howell D, et al. Factors Associated With Opioid Use in Long-term Cancer Survivors. J Pain Symptom Manage 2019; 58:100.
Harrington CB, Hansen JA, Moskowitz M, et al. It's not over when it's over: long-term symptoms in cancer survivors--a systematic review. Int J Psychiatry Med 2010; 40:163.
Brown LF, Kroenke K. Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 2009; 50:440.
Institute of Medicine of the National Academies Board on Health Care Services. Cancer care for the whole patient: meeting psychosocial health needs. The National Academies Press; Washington, D.C., 2007.
Foster C, Wright D, Hill H, et al. Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eur J Cancer Care (Engl) 2009; 18:223.
Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol 2012; 30:1215.
Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol 2012; 30:1160.
Jacobsen PB, Holland JC, Steensma DP. Caring for the whole patient: the science of psychosocial care. J Clin Oncol 2012; 30:1151.
Boland EG, Ahmedzai SH. Persistent pain in cancer survivors. Curr Opin Support Palliat Care 2017; 11:181.
Kurita GP, Sjøgren P. Pain management in cancer survivorship. Acta Oncol 2015; 54:629.
Jiang C, Wang H, Wang Q, et al. Prevalence of Chronic Pain and High-Impact Chronic Pain in Cancer Survivors in the United States. JAMA Oncol 2019; 5:1224.
Hayek S, Brinkman TM, Plana JC, et al. Association of Exercise Intolerance With Emotional Distress, Attainment of Social Roles, and Health-Related Quality of Life Among Adult Survivors of Childhood Cancer. JAMA Oncol 2020; 6:1194.
Weaver KE, Forsythe LP, Reeve BB, et al. Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2012; 21:2108.
Craft LL, Vaniterson EH, Helenowski IB, et al. Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012; 21:3.
Mishra SI, Scherer RW, Snyder C, et al. Are exercise programs effective for improving health-related quality of life among cancer survivors? A systematic review and meta-analysis. Oncol Nurs Forum 2014; 41:E326.
Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004; 101:1712.
Yu X, McBean AM, Virnig BA. Physician visits, patient comorbidities, and mammography use among elderly colorectal cancer survivors. J Cancer Surviv 2007; 1:275.
Duffy CM, Clark MA, Allsworth JE. Health maintenance and screening in breast cancer survivors in the United States. Cancer Detect Prev 2006; 30:52.
Snyder CF, Frick KD, Herbert RJ, et al. Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol 2013; 31:1140.
Klosky JL, Tyc VL, Garces-Webb DM, et al. Emerging issues in smoking among adolescent and adult cancer survivors: a comprehensive review. Cancer 2007; 110:2408.
Mariotto AB, Rowland JH, Ries LA, et al. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 2007; 16:566.
Centers for Disease Control and Prevention, National Center for Health Statistics. National Health Interview Survey https://www.cdc.gov/nchs/nhis/index.htm (Accessed on June 02, 2021).
Underwood JM, Townsend JS, Stewart SL, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors--Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ 2012; 61:1.
Yabroff KR, Lawrence WF, Clauser S, et al. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst 2004; 96:1322.
